CXCL8 and neoplasm: The endpoint of Lineage 4 (Cluster 5; Supplementary Table S4) was enriched for the chemokine CXCL8 (Fig. 2F and G), the major ligand for G-Protein coupled receptor CXCR2 and associated with immune suppression and tumor progression in this context (32).